CN114403277A - Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof - Google Patents
Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof Download PDFInfo
- Publication number
- CN114403277A CN114403277A CN202111678023.4A CN202111678023A CN114403277A CN 114403277 A CN114403277 A CN 114403277A CN 202111678023 A CN202111678023 A CN 202111678023A CN 114403277 A CN114403277 A CN 114403277A
- Authority
- CN
- China
- Prior art keywords
- extract
- milk
- alcohol
- flavored
- candy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 77
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 239000000843 powder Substances 0.000 claims abstract description 52
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 21
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 19
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 19
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 235000009566 rice Nutrition 0.000 claims abstract description 16
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 14
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 14
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 14
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 235000020186 condensed milk Nutrition 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- 235000008939 whole milk Nutrition 0.000 claims abstract description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 11
- 229920001202 Inulin Polymers 0.000 claims abstract description 11
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 11
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 11
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 11
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 11
- 229940029339 inulin Drugs 0.000 claims abstract description 11
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 11
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 11
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 11
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 11
- 239000000600 sorbitol Substances 0.000 claims abstract description 11
- 240000007594 Oryza sativa Species 0.000 claims abstract 4
- 238000001035 drying Methods 0.000 claims description 31
- 206010019133 Hangover Diseases 0.000 claims description 26
- 238000005507 spraying Methods 0.000 claims description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- 239000011812 mixed powder Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 14
- 239000004373 Pullulan Substances 0.000 claims description 13
- 229920001218 Pullulan Polymers 0.000 claims description 13
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 13
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 13
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 13
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 13
- 235000019423 pullulan Nutrition 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 239000004376 Sucralose Substances 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 9
- 235000019408 sucralose Nutrition 0.000 claims description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 239000007888 film coating Substances 0.000 claims description 3
- 238000009501 film coating Methods 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 208000007848 Alcoholism Diseases 0.000 abstract description 12
- 201000007930 alcohol dependence Diseases 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 7
- 230000002075 anti-alcohol Effects 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 235000019658 bitter taste Nutrition 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 230000009044 synergistic interaction Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 24
- 230000035622 drinking Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 241000209094 Oryza Species 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- 240000006365 Vitis vinifera Species 0.000 description 5
- 235000014787 Vitis vinifera Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 229960002920 sorbitol Drugs 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 238000000540 analysis of variance Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010006326 Breath odour Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000001188 Peltandra virginica Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000219780 Pueraria Species 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 241000405398 Hovenia Species 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000011363 dried mixture Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a milk-flavored alcohol-dispelling tabletting candy and a preparation method thereof, wherein the milk-flavored alcohol-dispelling tabletting candy comprises the following raw material mixtures in percentage by mass: 2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 0-8% of medlar extract, 0-5% of liquorice extract, 0-5% of poria cocos extract, 0-2.5% of rice protein peptide, 10-25% of whole milk powder, 0-10% of sorbitol, 0-10% of maltodextrin, 0-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 0-10% of long-chain inulin. The main anti-alcohol components of the invention are kudzu root and hovenia dulcis thunb, poria cocos is a heat-clearing and diuresis-inducing medicine, medlar nourishes kidney and tonifies liver, liquorice is heat-clearing and detoxifying, and the compatibility of the medlar and hovenia dulcis thunb can realize synergistic interaction, thus improving the effect of relieving alcoholism; the rice protein peptide can accelerate the degradation of ethanol in vivo; the components cooperate with each other to effectively remove the bitter taste, ensure the tablet forming effect, complete tablet shape without powder falling and moderate hardness.
Description
Technical Field
The invention belongs to the technical field of functional food processing, and particularly relates to a milk-flavored hangover alleviating tabletting candy and a preparation method thereof.
Background
Wine culture permeates the whole civilization history of China, and proper drinking can promote blood circulation, dredge collaterals, dispel cold, dispel dampness, relieve pain, regulate mood, eliminate fatigue, relieve tension and the like, but acute excessive drinking can cause nausea, vomiting, hypomnesis and inattention, and can die due to respiratory muscle paralysis in severe cases. The long-term drinking can cause serious diseases such as alcoholic hepatitis, fatty liver, liver cirrhosis and the like. With the development of economy, the continuous improvement of living standard and the increase of interpersonal communication activities. The phenomenon of over-drinking and the diseases and problems caused by alcohol are increasing, and how to reduce the harm of alcohol to health becomes a hot concern of the public. At present, the annual sale of wine in China is about 10000 hundred million, and the number of people drinking wine reaches 6 hundred million. Assuming that there is a demand for only 1% of the products capable of consuming the anti-hangover product, there will also be 600 million people. The market scale of the anti-alcoholism product can reach 43 hundred million by consuming 20 yuan every 10 days. It can be said that the drinking market is large, and the hangover alleviating market is large. Therefore, the research and development of corresponding anti-intoxication products, anti-alcoholism products and products for reducing the liver injury caused by long-term drinking have practical significance and broad prospect.
The existing anti-alcohol product market is mostly occupied by foreign health food brands, and the anti-alcohol product market has no restrictions on raw and auxiliary materials of the product. Most of domestic anti-alcoholic products only can use the kudzuvine root and the raisin tree seed as main functional components, but the products have poor palatability, cannot cover the bitter taste and the astringent taste of the kudzuvine root and the raisin tree seed, or have low content of the kudzuvine root and the raisin tree seed, and cannot achieve the expected effect. Therefore, the development of a product with high content of kudzu root and raisin tree seed and good palatability has practical significance.
Disclosure of Invention
The invention aims to overcome the technical defects and provides the milk-flavored alcohol-dispelling tabletted candy and the preparation method thereof.
In order to achieve the technical purpose, the technical scheme of the hangover alleviating tabletting candy is as follows:
the material comprises the following raw material mixtures in percentage by mass:
2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 0-8% of medlar extract, 0-5% of liquorice extract, 0-5% of poria cocos extract, 0-2.5% of rice protein peptide, 10-25% of whole milk powder, 0-10% of sorbitol, 0-10% of maltodextrin, 0-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 0-10% of long-chain inulin.
Further, the material comprises the following raw material mixture in percentage by mass:
2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 3-8% of medlar extract, 0.5-5% of liquorice extract, 0.5-5% of poria cocos extract, 0.5-2.5% of rice protein peptide, 10-25% of whole milk powder, 5-10% of sorbitol, 5-10% of maltodextrin, 5-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 5-10% of long-chain inulin.
Further, the mass ratio of the raw material mixture to the raw material mixture is 0.1-0.15: 100 of sucralose.
Further, the mass ratio of the raw material mixture to the raw material mixture is 0.5-1.5: 100 parts of magnesium stearate.
Further, the raw material mixture is a tabletting layer raw material of the tabletting candy, the tabletting candy further comprises a coating agent coated on the tabletting layer, and the mass ratio of the coating agent to the raw material mixture is 0.1-0.4: 100.
Further, the coating agent comprises pullulan and hydroxypropyl methyl cellulose.
The technical scheme of the preparation method of the hangover alleviating tabletting candy is as follows: the method comprises the following steps:
uniformly mixing the raw materials to obtain mixed powder, spraying alcohol into the mixed powder, continuously shaking until the powder is completely formed into granules A, sieving the granules A, and drying to obtain granules B; tabletting the granules B, and drying the obtained tabletting layer to obtain the milk-flavored alcohol-dispelling tabletting candy.
Further, the method also comprises the following steps: spraying alcohol into the granules B, adding magnesium stearate, mixing uniformly, and tabletting;
the ratio of the mixed powder to the alcohol was 100 g: (14-16) mL; the proportion of the particles B and the alcohol is 100 g: (4-6) mL; the volume fraction of the alcohol is 90%.
Further, the method also comprises the following steps: uniformly spraying a coating agent solution on the dried tablet layer, and drying again to obtain the milk-flavored alcohol-dispelling tablet candy; the film agent solution is a mixture solution of 30g/L hydroxypropyl methylcellulose and 20g/L pullulan.
Further, the sieving is 20-mesh sieving; the drying is carried out for 1-2.5 h at 40-60 ℃.
Compared with the prior art, the invention has the beneficial effects that:
the raw materials of the invention comprise bioactive components such as kudzu root extract, hovenia dulcis thunb extract, medlar extract, liquorice extract, tuckahoe extract, rice protein peptide and the like, and the main components for relieving alcoholism are kudzu root and hovenia dulcis thunb; the poria cocos is a heat-clearing and diuresis-inducing medicine, the medlar nourishes the kidney and the liver, the liquorice clears heat and detoxifies, and the compatibility of the medlar and the hovenia dulcis can realize synergistic interaction, so that the effect of relieving alcoholism is improved; the rice protein peptide has the functions of resisting oxidation, lowering blood pressure and accelerating body recovery, is rich in amino acids required by human bodies, and can accelerate the degradation of ethanol in the bodies. After the test that the alcohol effect dispelling tabletted candy is taken before drinking, the average blood alcohol concentration is reduced by 6.5-7.85% and the maximum blood alcohol concentration is reduced by 22.2% after 1h and 2h of drinking compared with the candy which is not taken; meanwhile, the substances of all the components are cooperated to effectively remove the bitter taste, the smell is fragrant, the sweetness is moderate, the tablet forming effect is ensured, the tablet is complete and does not fall off, and the hardness is moderate. In conclusion, the hangover alleviating tabletting candy disclosed by the invention is good in taste, and is beneficial to improving the alcohol content, relieving drunkenness and relieving drunkenness discomfort.
Drawings
Fig. 1 is a route chart of a preparation process of the milk-flavored anti-alcohol tabletted candy.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The tablet candy comprises the following raw material mixture in percentage by mass: 2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 0-8% of medlar extract, 0-5% of liquorice extract, 0-5% of poria cocos extract, 0-2.5% of rice protein peptide, 10-25% of whole milk powder, 0-10% of sorbitol, 0-10% of maltodextrin, 0-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 0-10% of long-chain inulin;
the raw material mixture also comprises 0.1-0.15% of sucralose, 0.5-1.5% of magnesium stearate, 0.05-0.2% of pullulan and 0.05-0.2% of hydroxypropyl methyl cellulose based on 100 parts by mass of the raw material mixture.
The tradenames of the extracts in the raw materials of the invention are kudzu root powder, hovenia dulcis thunb powder, medlar powder, liquorice powder and tuckahoe powder respectively, the extracts are powder extracted by using water as a solvent, the types of the extracts are 10:1(10g of the raw materials obtain 1g of extract powder), the concentration of water-soluble functional components is far higher than that of plant raw materials, and the extracts are named as the extracts in order to distinguish the extracts from the powder directly dried and crushed by the plant raw materials.
The radix Puerariae is dried root of Pueraria lobata Ohwi or Pueraria thomsonii of Pueraria of Leguminosae. The medicine is originally recorded in Shennong Ben Cao Jing, is sweet, pungent and cool in taste, and has the effects of relieving muscles and allaying fever, promoting the production of body fluid, relieving restlessness and quenching thirst, and invigorating yang and stopping diarrhea. The kudzuvine root not only has rich nutrition, but also contains isoflavone drug effect components such as daidzein, puerarin and the like, and belongs to a natural plant with homology of medicine and food approved by the Ministry of health. Recent pharmacological research proves that the pueraria flavonid has the effects of reducing myocardial oxygen consumption, increasing blood flow of coronary artery and cerebral vessels, obviously relieving angina, resisting arrhythmia and the like.
The puerarin contained in the kudzu root extract adopted by the invention can improve the visceral circulation and increase the tissue oxygen supply; improving the spasticity of the renal tubules to increase renal blood flow, increase urine volume, and enhance excretion, thereby reducing the level of ethanol in the blood; the product has effects of scavenging oxygen free radicals, resisting lipid peroxidation, recovering abnormal change of blood serum viscosity caused by alcoholism to normal state, improving general symptoms of patients, accelerating disappearance of intoxication symptoms, increasing alcohol yield, relieving intoxication, and relieving discomfort.
Semen Hoveniae is seed of Hovenia dulcis Thunb of Rhamnaceae, has sweet and sour taste, is nontoxic, has effects of clearing heat, promoting urination and relieving alcoholism, and is used for treating diseases pity such as alcoholism, dysphoria with smothery sensation, thirst, emesis, and dysuria. Modern researches prove that the hovenia plant contains saponin, flavone, alkaloid and other components and has pharmacological effects of resisting lipid peroxidation, protecting liver, relieving alcoholism, inhibiting central nerve and the like.
The raisin tree seed can play a role in preventing different drunkenness states of animals at different periods, can resist the inhibiting effect of the central nervous system caused by alcohol and the exciting effect of the central nervous system caused by alcohol, has the functions of relieving and eliminating various adverse effects such as ataxia, learning and memory disorder and the like caused by alcohol, can reduce the concentration of ethanol in blood and can influence the activity of ethanol dehydrogenase in liver. The effect of hovenia dulcis thunb in reducing the concentration of ethanol in blood can be related to the following two ways: (I) inhibiting or reducing the absorption of ethanol by the gastrointestinal tract, and enhancing the first-pass effect of ethanol in the gastrointestinal tract; (2) the activity of alcohol dehydrogenase in liver is enhanced, and the decomposition of alcohol in liver is accelerated.
Referring to fig. 1, the preparation method of the present invention comprises the following steps:
(1) mixing radix Puerariae extract, semen Hoveniae extract, fructus Lycii extract, Glycyrrhrizae radix extract, Poria extract, and rice protein peptide at a certain ratio to obtain premixed medicinal powder.
(2) Mixing the premixed powder with whole milk powder, sorbitol, maltodextrin, microcrystalline cellulose, condensed milk powder, long-chain inulin and sucralose at a certain ratio uniformly in a stainless steel round tray, and spraying a certain amount of 90% alcohol. Continuously shaking the mixed powder in the spraying process until the mixed powder is completely granulated. Sieving with 20 mesh sieve, and extruding and sieving the raw materials which do not pass through the sieve by external force.
(3) And (4) drying the sieved raw material particles in a constant-temperature drying box. Spraying a certain amount of 90% alcohol into the dried granules again, shaking uniformly, and adding magnesium stearate according to a certain proportion. Uniformly mixing, tabletting, and pressing into a round piece with the weight of 0.6 g/grain by controlling the feeding amount, wherein the tabletting mold is a 10 mm-diameter circular arc surface mold; and putting the mixture into a constant-temperature drying oven again for drying. Weighing hydroxypropyl methylcellulose and pullulan, adding water to dissolve, preparing a mixed solution, namely pre-prepared coating agent, and pouring into a spray can for later use. And uniformly spraying a pre-prepared film coating agent on the front surface and the back surface of the dried tabletted candy, putting the tabletted candy into a constant-temperature drying oven for drying again, and taking out the dried tabletted candy to obtain the finished milk-flavored hangover-alleviating tabletted candy.
In the whole process, two sub-processes can be independently carried out, namely a pre-mixing medicine powder sub-process and a pre-prepared coating agent sub-process.
The present invention is further illustrated by the following specific examples.
Example one
Mixing radix Puerariae extract, semen Hoveniae extract, fructus Lycii extract, Glycyrrhrizae radix extract, Poria extract, and rice protein peptide at ratio of 10:10:5:1.2:1.3:2.5 to obtain premixed medicinal powder, which is a premixed medicinal powder sub-process.
Uniformly mixing the premixed medicinal powder with whole milk powder, sorbitol, maltodextrin, microcrystalline cellulose, condensed milk powder, long-chain inulin and sucralose in a stainless steel round tray at a ratio of 30:20:10:10:10:10:10:0.15, spraying 90% alcohol, wherein the ratio of the mixed powder to the 90% alcohol is 100:15(g: mL), and continuously shaking the mixed powder in the spraying process until the mixed powder is completely granulated. Sieving with 20 mesh sieve, and extruding and sieving the raw materials which do not pass through the sieve by external force. And (3) putting the sieved raw material particles into a constant-temperature drying box, and drying for 2 hours at 50 ℃.
Spraying 90% ethanol again into the dried granules, mixing the powder and 90% ethanol at a ratio of 100:5(g: mL), shaking, and adding magnesium stearate at a ratio of 100:1. After being mixed evenly, the mixture is tabletted, is pressed into a round piece with the weight of about 0.6 g/grain by controlling the feeding amount, and is dried in a constant temperature drying oven at 50 ℃ for 2 hours.
Weighing hydroxypropyl methylcellulose and pullulan, adding water to dissolve, preparing a mixed solution containing 30g/L of hydroxypropyl methylcellulose and 20g/L of pullulan, namely a pre-prepared coating agent, and pouring into a spray can for later use. This is a pre-coating agent preparation sub-step.
Uniformly spraying a pre-prepared coating agent on the front side and the back side of the dried tabletted candy, controlling the addition amount by the sprayed volume, wherein the mass ratio of the hydroxypropyl methyl cellulose to the mixed powder is 0.1:100, and the mass ratio of the pullulan to the mixed powder is 0.07: 100. and (5) drying the mixture in a constant-temperature drying oven at 50 ℃ for 1 hour, and taking out the dried mixture to obtain the prepared milk-flavored hangover alleviating tabletting candy.
Test example 1
The alcohol effect dispelling test scheme comprises the following steps: the hangover alleviating tabletted candy prepared in the first example was subjected to a hangover alleviating test, and the experiment was divided into two times, namely, the hangover alleviating tabletted candy prepared in the first example (formula group) and the hangover alleviating tabletted candy prepared in the second example (blank control group) were used. This was done to compare the in vivo alcohol concentrations of each of the test subjects with and without the example anti-hangover tabletted confectioneries. The measurement was performed by a breath alcohol tester (which showed that the value was the blood alcohol concentration converted from the breath alcohol concentration).
The specific test steps are as follows:
in total, 10 volunteers were enrolled in the experiment, each of the enrollees was assigned 200mL of white spirit, and 3 tablets (experimental group) of anti-hangover tableting candies were taken 30min before drinking, while no anti-hangover tableting candies (blank control group) were taken. The breath alcohol concentration of the tested person is respectively measured 1h and 2h after drinking, and the average value is taken after three times of tests to reduce errors. The alcohol concentration (in mg/100mL) in the blood of the test subjects at 1h and 2h after drinking was measured according to the experimental protocol, and the results and analysis are shown in tables 1 to 4 below.
TABLE 1 alcohol concentration in blood 1h after drinking from different test subjects
| Serial number | Blank group (mg/100mL) | Experimental group (mg/100mL) |
| 1 | 120 | 99.7 |
| 2 | 116.3 | 103 |
| 3 | 108.7 | 117.7 |
| 4 | 128 | 105.3 |
| 5 | 106.3 | 109.3 |
| 6 | 114 | 120 |
| 7 | 116 | 126 |
| 8 | 117.3 | 109.7 |
| 9 | 135 | 105 |
| 10 | 126 | 102.3 |
TABLE 21 h analysis of variance of differences between test groups
| SUMMARY | ||||||
| Group of | Number of observations | Summing | Average | Variance (variance) | ||
| Column 1 | 10 | 1187.6 | 118.76 | 77.554 | ||
| Column 2 | 10 | 1098 | 109.8 | 75.216 | ||
| Analysis of variance | ||||||
| Source of difference | SS | df | MS | F | P-value | F crit |
| Between groups | 401.408 | 1 | 401.408 | 5.255 | 0.034 | 4.414 |
| In group | 1374.924 | 18 | 76.385 | |||
| Total of | 1776.332 | 19 |
TABLE 3 alcohol concentration in blood 2h after drinking of different test subjects
TABLE 42 h analysis of variance of differences between test groups
| SUMMARY | ||||||
| Group of | Number of observations | Summing | Average | Variance (variance) | ||
| Column 1 | 10 | 1102.6 | 110.26 | 87.432 | ||
| Column 2 | 10 | 1016 | 101.6 | 78.438 | ||
| Analysis of variance | ||||||
| Source of difference | SS | df | MS | F | P-value | F crit |
| Between groups | 374.978 | 1 | 374.978 | 4.521 | 0.048 | 4.414 |
| In group | 1492.824 | 18 | 82.937 | |||
| Total of | 1867.802 | 19 |
From the above experimental results in tables 1 to 4, it can be seen that after 1h of drinking, the alcohol concentration of the test group was reduced by up to 22% compared with the blank group, and the average value was reduced by 7.54% compared with the blank group; although the alcohol concentration of the test subjects in a few test groups after drinking is higher than that of the blank group due to individual difference within 1h, the alcohol concentration of the test subjects is lower than that of the blank group after 2h, the reduction rate of the alcohol concentration is 2.7-12.68% after 2h, and the average value is 7.85%. Therefore, the mean value of the alcohol concentration of the experimental group is smaller than that of the blank group, and the variance analysis shows that the difference between the groups is obvious (P is 0.034 and is less than 0.05, and P is 0.048 and is less than 0.05), which indicates that the anti-alcoholism tablet candy has a certain anti-alcoholism effect.
Example two
The taste and the anti-alcohol effect of the tabletted candies obtained by the different components are examined.
Respectively removing Glycyrrhrizae radix extract, fructus Lycii extract, Poria extract, rice protein peptide, whole milk powder, condensed milk powder, sucralose, magnesium stearate, pullulan and hydroxypropyl methylcellulose, respectively numbering test groups 2-1 to 2-6; meanwhile, test groups 2-7 are set, only the kudzu root extract and the hovenia dulcis thunb extract are reserved, and other conditions are the same as the first embodiment. The test results are shown in table 5 below.
TABLE 5 taste scoring and antialcoholism effect of different sugar components
As can be seen from Table 5, the alcohol concentration of the test groups 2-1 and 2-2 is not obviously reduced compared with the first embodiment, and the effects of the test groups 2-7 are basically the same, which indicates that the poria cocos is a heat-clearing and diuresis-promoting drug, the medlar is capable of nourishing kidney and liver, the liquorice is capable of clearing heat and detoxifying, and the compatibility of the poria cocos with the radix puerariae and the hovenia dulcis thunb can synergize to improve the effect of relieving alcoholism; the rice protein peptide can accelerate the degradation of ethanol in vivo; meanwhile, the components cooperate with each other to play a role in neutralization, so that the bitter taste is effectively removed, the tablet forming effect is ensured, and the tablet is complete without powder falling.
Therefore, the bitter taste and astringent taste of the kudzu root extract and the hovenia dulcis thunb extract can be effectively reduced and the anti-inebriation effect of the kudzu root extract and the hovenia dulcis thunb extract can be improved by matching the components.
EXAMPLE III
The effect of different process conditions on the resulting tabletted confectioneries was investigated.
The amount of alcohol sprayed for granulation, the amount of alcohol sprayed before tabletting, the temperature of the oven, the coating process and the like were respectively changed and numbered as test groups 3-1 to 3-6, and the other conditions were the same as in example one. The test results are shown in table 6 below.
TABLE 6 sensory hardness scores for tabletted saccharides from different processes
As can be seen from table 6, the final tablets were adversely affected by spraying too much alcohol or not during granulation and tabletting, either too loose and brittle to facilitate transport or too hard to bite and absorb quickly.
Example four
Mixing radix Puerariae extract, semen Hoveniae extract, fructus Lycii extract, Glycyrrhrizae radix extract, Poria extract, and rice protein peptide at a mass ratio of 12:12:3:0.5:0.5:2 to obtain premixed medicinal powder.
Uniformly mixing the premixed medicinal powder, the whole milk powder, sorbitol, maltodextrin, microcrystalline cellulose, condensed milk powder, long-chain inulin and sucralose according to the mass ratio of 30:25:5:8:7:15:10: 0.1; spraying 90% alcohol, wherein the ratio of the mixed powder to the 90% alcohol is 100:14(g: mL); drying at 40 deg.C for 2.5 h.
Spraying 90% alcohol again, mixing the powder and 90% alcohol at a ratio of 100:6(g: mL), shaking, and adding magnesium stearate at a ratio of 100: 1.5. Drying at 40 deg.C for 2.5h after tabletting.
Uniformly spraying a pre-prepared coating agent on the front side and the back side of the dried tablet, controlling the addition amount by the sprayed volume, wherein the mass ratio of the hydroxypropyl methyl cellulose to the mixed powder is 0.05:100, and the mass ratio of the pullulan to the mixed powder is 0.05: 100. and drying in a constant-temperature drying oven at 40 ℃ for 1.5h to obtain the milk-flavored alcohol-dispelling tabletting candy.
EXAMPLE five
Mixing radix Puerariae extract, semen Hoveniae extract, fructus Lycii extract, Glycyrrhrizae radix extract, Poria extract, and rice protein peptide at a mass ratio of 14.5:2.5:7.5:5:5:0.5 to obtain premixed medicinal powder.
Uniformly mixing the premixed medicinal powder, the whole milk powder, sorbitol, maltodextrin, microcrystalline cellulose, condensed milk powder, long-chain inulin and sucralose according to the mass ratio of 35:15:10:5:10:15:10: 0.12; spraying 90% alcohol, wherein the ratio of the mixed powder to the 90% alcohol is 100:16(g: mL); drying at 60 deg.C for 1 h.
Spraying 90% alcohol again, mixing the powder and 90% alcohol at a ratio of 100:4(g: mL), shaking, and adding magnesium stearate at a ratio of 100: 0.5. Drying at 60 deg.C for 1h after tabletting.
Uniformly spraying a pre-prepared coating agent on the front side and the back side of the dried tablet, controlling the addition amount by the sprayed volume, wherein the mass ratio of the hydroxypropyl methyl cellulose to the mixed powder is 0.2:100, and the mass ratio of the pullulan to the mixed powder is 0.08: 100. and drying in a constant-temperature drying oven at 40 ℃ for 1h to obtain the milk-flavored alcohol-dispelling tabletting candy.
EXAMPLE six
Mixing the kudzu root extract, the hovenia dulcis thunb extract, the medlar extract, the liquorice extract, the tuckahoe extract and the rice protein peptide according to the mass ratio of 2.5:15:8:2:1:1.5 to obtain premixed medicinal powder.
Uniformly mixing the premixed medicinal powder, the whole milk powder, sorbitol, maltodextrin, microcrystalline cellulose, condensed milk powder, long-chain inulin and sucralose according to the mass ratio of 30:25:10:10:10:10:5: 0.12; spraying 90% alcohol, wherein the ratio of the mixed powder to the 90% alcohol is 100:15(g: mL); drying at 55 deg.C for 1.5 h.
Spraying 90% alcohol again, mixing the powder and 90% alcohol at a ratio of 100:5(g: mL), shaking, and adding magnesium stearate at a ratio of 100:1. After tabletting, drying was carried out at 55 ℃ for 1.5 h.
Uniformly spraying a pre-prepared coating agent on the front side and the back side of the dried tablet, controlling the addition amount by the sprayed volume, wherein the mass ratio of the hydroxypropyl methyl cellulose to the mixed powder is 0.1:100, and the mass ratio of the pullulan to the mixed powder is 0.2: 100. and drying in a constant-temperature drying oven at 50 ℃ for 1h to obtain the milk-flavored hangover alleviating tabletting candy.
Through tests, the effect of the tabletted candies obtained in the fourth to sixth examples is slightly reduced compared with that of the first example, but compared with a control group which does not take the tabletted candies, the invention can still reduce the mean value of the blood alcohol concentration of the subjects within 1h and 2h by 6.5-7.48 and maximally by 19.8%, and the obtained tabletted candies have good mouthfeel.
The hangover alleviating tabletting candy disclosed by the invention is good in taste, and is beneficial to improving the wine capacity, relieving drunkenness and relieving drunkenness discomfort.
The above-described embodiments of the present invention should not be construed as limiting the scope of the present invention. Any other corresponding changes and modifications made according to the technical idea of the present invention should be included in the protection scope of the claims of the present invention.
Claims (10)
1. A milk-flavored alcohol-dispelling tabletting candy is characterized in that: the material comprises the following raw material mixtures in percentage by mass:
2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 0-8% of medlar extract, 0-5% of liquorice extract, 0-5% of poria cocos extract, 0-2.5% of rice protein peptide, 10-25% of whole milk powder, 0-10% of sorbitol, 0-10% of maltodextrin, 0-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 0-10% of long-chain inulin.
2. The milk-flavored anti-hangover tabletted candy as claimed in claim 1, wherein: the material comprises the following raw material mixtures in percentage by mass:
2.5-15% of kudzu root extract, 2.5-15% of hovenia dulcis thunb extract, 3-8% of medlar extract, 0.5-5% of liquorice extract, 0.5-5% of poria cocos extract, 0.5-2.5% of rice protein peptide, 10-25% of whole milk powder, 5-10% of sorbitol, 5-10% of maltodextrin, 5-10% of microcrystalline cellulose, 5-15% of condensed milk powder and 5-10% of long-chain inulin.
3. The milk-flavored anti-hangover tabletted candy as claimed in claim 1, wherein: the mass ratio of the raw material mixture to the raw material mixture is 0.1-0.15: 100 of sucralose.
4. The milk-flavored anti-hangover tabletted candy as claimed in claim 1, wherein: the mass ratio of the raw material mixture to the raw material mixture is 0.5-1.5: 100 parts of magnesium stearate.
5. The milk-flavored anti-hangover tabletted candy as claimed in claim 1, wherein: the raw material mixture is a tabletting layer raw material of the tabletting candy, the tabletting candy further comprises a film coating agent coated on the tabletting layer, and the mass ratio of the film coating agent to the raw material mixture is 0.1-0.4: 100.
6. The milk-flavored anti-hangover tabletted candy as claimed in claim 5, wherein: the coating agent comprises pullulan polysaccharide and hydroxypropyl methylcellulose.
7. The method for preparing a milk-flavored anti-hangover tabletted candy as claimed in claim 1, wherein: the method comprises the following steps:
uniformly mixing the raw materials to obtain mixed powder, spraying alcohol into the mixed powder, continuously shaking until the powder is completely formed into granules A, sieving the granules A, and drying to obtain granules B; tabletting the granules B, and drying the obtained tabletting layer to obtain the milk-flavored alcohol-dispelling tabletting candy.
8. The method for preparing a milk-flavored anti-hangover tabletted candy as claimed in claim 7, wherein: further comprising the steps of: spraying alcohol into the granules B, adding magnesium stearate, mixing uniformly, and tabletting;
the ratio of the mixed powder to the alcohol was 100 g: (14-16) mL; the proportion of the particles B and the alcohol is 100 g: (4-6) mL; the volume fraction of the alcohol is 90%.
9. The method for preparing a milk-flavored anti-hangover tabletted candy as claimed in claim 7, wherein: further comprising the steps of: uniformly spraying a coating agent solution on the dried tablet layer, and drying again to obtain the milk-flavored alcohol-dispelling tablet candy; the film agent solution is a mixture solution of 30g/L hydroxypropyl methylcellulose and 20g/L pullulan.
10. The method for preparing a milk-flavored anti-hangover tabletted candy as claimed in claim 7, wherein: the sieving is to sieve by a 20-mesh sieve; the drying is carried out for 1-2.5 h at 40-60 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111678023.4A CN114403277A (en) | 2021-12-31 | 2021-12-31 | Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111678023.4A CN114403277A (en) | 2021-12-31 | 2021-12-31 | Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114403277A true CN114403277A (en) | 2022-04-29 |
Family
ID=81271388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111678023.4A Pending CN114403277A (en) | 2021-12-31 | 2021-12-31 | Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114403277A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114767747A (en) * | 2022-05-09 | 2022-07-22 | 上海丰晟健康科技有限公司 | Preparation method of alcohol effect dispelling product |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606612A (en) * | 2015-01-05 | 2015-05-13 | 王元忠 | Alcohol-expelling kidney-tonifying tablet candy and preparation method thereof |
-
2021
- 2021-12-31 CN CN202111678023.4A patent/CN114403277A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104606612A (en) * | 2015-01-05 | 2015-05-13 | 王元忠 | Alcohol-expelling kidney-tonifying tablet candy and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 西安千益生物工程有限公司: "蛹虫草压片糖果", 西安千益生物工程有限公司企业标准 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114767747A (en) * | 2022-05-09 | 2022-07-22 | 上海丰晟健康科技有限公司 | Preparation method of alcohol effect dispelling product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101789424B1 (en) | Medicinal-Herb Composition Comprising Chinese matrimony vine Proving Insomniac and the Method of Making the Same | |
| CN102524781A (en) | Edible composition with alcoholism alleviation function and preparation method thereof | |
| CN111053238A (en) | Functional food with functions of relieving pressure and helping sleep and preparation method thereof | |
| CN113841892A (en) | Food formula with sleep-aiding function and preparation method and application thereof | |
| CN108498597A (en) | A kind of sobering-up composition | |
| CN113768004A (en) | White tea seasoning tea containing dried orange peel and preparation method thereof | |
| CN109222100A (en) | A kind of ginseng Cordyceps militaris composition, ginseng Cordyceps militaris pressed candy and preparation method thereof | |
| CN103719491A (en) | Rhizoma polygonati health-care tea for invigorating spleen and moistening lung and preparation method thereof | |
| CN110613134B (en) | Health food with blood sugar reducing function and preparation method thereof | |
| CN114403277A (en) | Milk-flavored alcohol-dispelling tabletted candy and preparation method thereof | |
| CN101190250B (en) | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof | |
| CN111643563B (en) | Composition for harmonizing stomach, protecting liver and dispelling effects of alcohol and preparation method thereof | |
| KR20200087606A (en) | Compositions for Improving Memory Power and Learning Ability, and Relaxing stress | |
| CN114403278A (en) | Hawthorn fruit-flavored alcohol-dispelling tabletting candy and preparation method thereof | |
| CN114377109A (en) | Nerve-soothing and sleep-aiding composition and preparation method and application thereof | |
| CN113632979A (en) | Four-season health-preserving beverage for men and women and preparation method thereof | |
| CN107183426B (en) | Liver-protecting and alcohol-dispelling plant beverage, and preparation method and application thereof | |
| CN104013888A (en) | Traditional Chinese medicine composition for treating phlegm-heat lung-stagnation type obstructive emphysema and preparation method thereof | |
| CN104352794A (en) | Traditional Chinese medicine preparation for treating lung yin deficiency type xerophthalmia | |
| CN108379500A (en) | A kind of wheat seeding Chinese medicine composition that nourishing the liver Dealcoholic sobering-up is anti-halitosis and preparation method | |
| AU2020103237A4 (en) | Application of Rabdosia Serra in Preventing or Treating Alcohol Dependence | |
| CN111053858B (en) | Spleen-tonifying and probiotic health-care tea containing traditional Chinese medicine codonopsis pilosula and preparation method thereof | |
| CN115737747B (en) | Traditional Chinese medicine composition for improving memory and preventing and treating senile dementia and application thereof | |
| CN1814165B (en) | Pulse-promoting slow-release capsule and preparing method | |
| CN109549193A (en) | A kind of Chinese medicine compound prescription improves the health food and preparation method thereof of sleep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |